Newsroom

  • Ending the TB Epidemic Jan 25, 2017

    ACTION welcomes the Medicines Patent Pool’s first license for new TB treatment

    25 January 2017 – ACTION welcomes the signing of a licensing agreement between the Medicine Patent Pool (MPP) and the Johns Hopkins University, for an investigational tuberculosis (TB) treatment. The drug, sutezolid, holds significant promise for an effective new treatment for the world’s leading infectious killer. The signing, which took place, January 24 in Geneva, Switzerland, is the first licensing agreement for TB treatment announced by the MPP.

    Read more
  • Ending the TB Epidemic Oct 13, 2016

    Tuberculosis cases top 10 million

    Drug-resistant TB cases up to 580,000. 13 October 2016 – New data released today by the World Health Organization shows that the tuberculosis (TB) epidemic is bigger than anyone had previously counted. There are now more cases, more deaths, and more drug resistance on record. This is the third year in a row that the estimate of total TB cases and deaths has been revised upward.

    Read more
  • Ending the TB Epidemic Sep 17, 2016

    World leaders invest nearly $13 bn in the Global Fund, build momentum toward ending the epidemic

    Further efforts to build on this investment are needed in the years ahead to put the diseases in the history books

    Read more
  • Ending the TB Epidemic Jul 19, 2016

    New ACTION Report Urges Integrated Response to TB-HIV

    July 19, 2016 — ACTION released a new report today that highlights the persistent need to coordinate an integrated response to the deadly duo of TB-HIV co-infections if additional progress is to be made against either disease.

    Read more
  • Ending the TB Epidemic Jul 18, 2016

    MEDIA ADVISORY

    Media advisory for a press conference on ACTION’s new TB-HIV research, "From Policy to Practice: How the TB-HIV Response is Working." ACTION, a global health advocacy partnership, will released a new report highlighting the persistent need to coordinate an integrated response to the "deadly duo" of TB-HIV co-infections if additional progress is to be made against either disease.

    Read more
  • Ending the TB Epidemic May 19, 2016

    AMR Review Highlights Window of Opportunity to Combat World’s Top Infectious Killer

    A groundbreaking report released today by the independent Review of Antimicrobial Resistance (AMR) in the U.K. presents a window of opportunity to transform the fight against TB, the world’s deadliest infectious disease.

    Read more
  • Ending the TB Epidemic Mar 24, 2016

    2016: A Year of Opportunities and Action on TB

    Last fall, we learned a frightening truth: tuberculosis (TB) is now the leading infectious killer in the world, surpassing HIV/AIDS. But with distressing numbers came exciting solutions. If we seize them, a new set of opportunities could end TB in our generation.

    Read more
  • Dec 01, 2015

    Remembering Kraig Klaudt

    As an ACTION partnership we are deeply saddened by the passing of Kraig Klaudt, one of ACTION’s founders and a deeply-dedicated, passionate, and visionary leader in the fight against TB and other diseases of poverty.

    Read more